{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:16:27Z","timestamp":1787163387499,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>X-linked hypohidrotic ectodermal dysplasia (XLHED) is a severe genetic disorder that may be treatable with short-term protein replacement therapy during fetal development. This is currently being investigated in a multicenter clinical trial. Affected fetuses can be identified by the number of tooth germs during a routine ultrasound scan in mid-gestation. To understand the attitudes of female XLHED carriers towards prenatal treatment and ultrasonographic screening of the fetus, we analyzed an earlier and a very recent survey among those women and the actual decisions of potential trial participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Initial analyses were based on a self-administered survey of 167 female XLHED carriers conducted in 2011. A similar questionnaire was completed 12 years later by 72 female XLHED carriers aged 18\u201345 years. Subsequently, both the path to diagnosis and further decision-making of the first 33 pregnant women screened for participation in the EDELIFE trial were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most women diagnosed with XLHED considered this disease as an obstacle to having children: About one third had decided not to have children, another third would monitor their pregnancy using invasive genetic testing. In both surveys, a small number of women stated that they would consider termination of pregnancy depending on the test result. When it came to participating in the clinical trial, 80% were likely to take part (17% moderately likely, 63% very likely). Among the first pregnant women screened for this trial, 48% underwent invasive tests, while 52% relied on non-invasive tooth germ imaging for fetal XLHED diagnosis. One pregnancy with an affected fetus was terminated, another one resulted in a miscarriage, one woman declined to participate in the trial, and 12 women (80%) decided to have the affected fetuses treated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ultrasound-based screening and prenatal treatment of the fetus are viewed positively by the vast majority of female XLHED carriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03710-7","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:21:52Z","timestamp":1744723312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Attitudes of female carriers of X-linked hypohidrotic ectodermal dysplasia towards prenatal treatment and their decisions during a pregnancy with a male fetus"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-4053","authenticated-orcid":false,"given":"Holm","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Lia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy K.","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smail","family":"Hadj-Rabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Fete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Jaulent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Guiraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Odibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Faschingbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmg.2013.01.012","volume":"56","author":"M Nguyen-Nielsen","year":"2013","unstructured":"Nguyen-Nielsen M, Skovbo S, Svaneby D, et al. The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995\u20132010. Eur J Med Genet. 2013;56:236\u201342.","journal-title":"Eur J Med Genet"},{"key":"3710_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng0895-409","volume":"13","author":"J Kere","year":"1996","unstructured":"Kere J, Srivastava AK, Montonen O, et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet. 1996;13:409\u201316.","journal-title":"Nat Genet"},{"key":"3710_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1359-6101(03)00020-0","volume":"14","author":"ML Mikkola","year":"2003","unstructured":"Mikkola ML, Thesleff I. Ectodysplasin signaling in development. Cytokine Growth Factor Rev. 2003;14:211\u201324.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3710_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/jmg.2010.084012","volume":"48","author":"H Schneider","year":"2011","unstructured":"Schneider H, Hammersen J, Preisler-Adams S, et al. Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasia. J Med Genet. 2011;48:426\u201332.","journal-title":"J Med Genet"},{"key":"3710_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.earlhumdev.2010.04.008","volume":"86","author":"G Bl\u00fcschke","year":"2010","unstructured":"Bl\u00fcschke G, N\u00fcsken KD, Schneider H. Prevalence and prevention of severe complications of hypohidrotic ectodermal dysplasia in infancy. Early Hum Dev. 2010;86:397\u20139.","journal-title":"Early Hum Dev"},{"key":"3710_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1203\/PDR.0b013e318227503b","volume":"70","author":"J Hammersen","year":"2011","unstructured":"Hammersen J, Neukam V, N\u00fcsken KD, Schneider H. Systematic evaluation of exertional hyperthermia in children and adolescents with hypohidrotic ectodermal dysplasia: an observational study. Pediatr Res. 2011;70:297\u2013301.","journal-title":"Pediatr Res"},{"key":"3710_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/genes14010153","volume":"14","author":"H Schneider","year":"2023","unstructured":"Schneider H, Hadj-Rabia S, Faschingbauer F, et al. Protocol for the phase 2 EDELIFE trial investigating the efficacy and safety of intra-amniotic ER004 administration to male subjects with X-linked hypohidrotic ectodermal dysplasia. Genes. 2023;14:153.","journal-title":"Genes"},{"key":"3710_CR8","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.3390\/ijms24087155","volume":"24","author":"H Schneider","year":"2023","unstructured":"Schneider H, Schweikl C, Faschingbauer F, et al. A causal treatment for X-linked hypohidrotic ectodermal dysplasia: Long-term results of short-term perinatal Ectodysplasin A1 replacement. Int J Mol Sci. 2023;24:7155.","journal-title":"Int J Mol Sci"},{"key":"3710_CR9","first-page":"381","volume":"36","author":"S W\u00fcnsche","year":"2015","unstructured":"W\u00fcnsche S, J\u00fcngert J, Faschingbauer F, et al. Noninvasive prenatal diagnosis of hypohidrotic ectodermal dysplasia by tooth germ sonography. Ultraschall Med. 2015;36:381\u20135.","journal-title":"Ultraschall Med"},{"key":"3710_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/pd.5384","volume":"39","author":"J Hammersen","year":"2019","unstructured":"Hammersen J, Wohlfart S, Goecke T, et al. Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography. Prenat Diagn. 2019;39:796\u2013805.","journal-title":"Prenat Diagn"},{"key":"3710_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/pd.6228","volume":"42","author":"ME Schwab","year":"2022","unstructured":"Schwab ME, Shao S, Zhang L, et al. Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy. Prenat Diagn. 2022;42:1409\u201319.","journal-title":"Prenat Diagn"},{"key":"3710_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/hae.14805","volume":"29","author":"QDM Pham","year":"2023","unstructured":"Pham QDM, Thomson SM, Schaible BN, et al. Acceptability of prenatal diagnosis and prenatal treatment of haemophilia using cell and gene therapies within US haemophilia community. Haemophilia. 2023;29:1024\u201331.","journal-title":"Haemophilia"},{"key":"3710_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/jdv.18267","volume":"36","author":"B Leo","year":"2022","unstructured":"Leo B, Schneider H, Hammersen J. Reproductive decision-making by women with X-linked hypohidrotic ectodermal dysplasia. J Eur Acad Dermatol Venereol. 2022;36:1863\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3710_CR14","doi-asserted-by":"publisher","first-page":"1000744","DOI":"10.3389\/fgene.2022.1000744","volume":"13","author":"H Schneider","year":"2022","unstructured":"Schneider H. Ectodermal dysplasias: new perspectives on the treatment of so Far immedicable genetic disorders. Front Genet. 2022;13:1000744.","journal-title":"Front Genet"},{"key":"3710_CR15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/bcp.14301","volume":"86","author":"I K\u00f6rber","year":"2020","unstructured":"K\u00f6rber I, Klein O, Morhart P, et al. Safety and immunogenicity of Fc-EDA, a Recombinant Ectodysplasin A1 replacement protein, in human subjects. Br J Clin Pharmacol. 2020;86:2063\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"3710_CR16","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1056\/NEJMoa1714322","volume":"378","author":"H Schneider","year":"2018","unstructured":"Schneider H, Faschingbauer F, Schuepbach-Mallepell S, et al. Prenatal correction of X-linked hypohidrotic ectodermal dysplasia. N Engl J Med. 2018;378:1604\u201310.","journal-title":"N Engl J Med"},{"key":"3710_CR17","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1038\/jid.2014.264","volume":"134","author":"K Hermes","year":"2014","unstructured":"Hermes K, Schneider P, Krieg P, et al. Prenatal therapy in developmental disorders: drug targeting via intra-amniotic injection to treat X-linked hypohidrotic ectodermal dysplasia. J Invest Dermatol. 2014;134:2985\u20137.","journal-title":"J Invest Dermatol"},{"key":"3710_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1469-0705.1998.12040240.x","volume":"12","author":"MR Ulm","year":"1998","unstructured":"Ulm MR, Kratochwil A, Ulm B, et al. Three-dimensional ultrasound evaluation of fetal tooth germs. Ultrasound Obstet Gynecol. 1998;12:240\u20133.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3710_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.7863\/jum.2003.22.7.731","volume":"22","author":"W Sepulveda","year":"2003","unstructured":"Sepulveda W, Sandoval R, Carstens E, et al. Hypohidrotic ectodermal dysplasia: prenatal diagnosis by three-dimensional ultrasonography. J Ultrasound Med. 2003;22:731\u20135.","journal-title":"J Ultrasound Med"},{"key":"3710_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/jcu.23020","volume":"49","author":"TG Li","year":"2021","unstructured":"Li TG, Ma B, Tie HX, et al. Prenatal sonographic diagnosis of X-linked hypohidrotic ectodermal dysplasia: an unusual case. J Clin Ultrasound. 2021;49:838\u201340.","journal-title":"J Clin Ultrasound"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03710-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:21:53Z","timestamp":1744723313000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03710-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03710-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The XLHED Carrier Outlook toward Reproduction Survey (X-CORS) was approved by the institutional review board of Maine Medical Partners Pediatric Specialty Care Portland (USA) in July 2011. Ethical approval for the EDELIFE trial was obtained from the ethics committees at all participating study sites. The first institutional review board that approved this clinical trial was the ethics committee of the University of Erlangen-N\u00fcrnberg in Germany (reference number 264_21 Az; date of approval: September 20, 2021). Women who participated in the XLHED Carrier Outlook toward Reproduction Survey provided written informed consent. The second survey in 2023 (completed online) was carried out in such a way that the project could not link individual responses with participants\u2019 identities. In the EDELIFE trial, written informed consent of each pregnant woman and her partner was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HS received both public and private funding for the current EDELIFE trial (see below) and holds a patent related to the prenatal therapy of XLHED, but signed a Remuneration Waiver Agreement to relinquish any personal financial gain from this invention; he has had a consulting or advisory role, received honoraria, research grants, and\/or travel support from Edimer Pharmaceuticals, Krystal Biotech, Novartis, Pierre Fabre, Roche, SRE GmbH, and Wyeth Pharma GmbH. MG and AJ are employees of Pierre Fabre M\u00e9dicament and the EspeRare Foundation, respectively.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}